ClinicalTrials.Veeva

Menu

Ultra High Field Magnetic Resonance Imaging as a Biomarker for Premotor Parkinson's Disease

Oregon Health & Science University (OHSU) logo

Oregon Health & Science University (OHSU)

Status

Unknown

Conditions

REM Sleep Behavior Disorder
Parkinson Disease

Treatments

Other: MRI

Study type

Observational

Funder types

Other

Identifiers

NCT03288909
eIRB#5611

Details and patient eligibility

About

This is a prospective observational study investigating the utility of 7 Tesla MRI to quantify nigrosome1 signal in a cohort of individuals with recent onset Parkinson's disease and in at-risk cohorts at a premotor state of Parkinson's disease.

Enrollment

18 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Idiopathic Parkinson's disease within 1 year of motor symptom onset. Idiopathic REM sleep behavior disorder without signs/symptoms of Parkinson's disease.

Age-matched controls.

Exclusion criteria

  • Atypical Parkinsonism
  • Contraindications for MRI

Trial design

18 participants in 3 patient groups

Early onset Parkinson's disease
Description:
Idiopathic Parkinson's disease within 1 year of symptom onset
Treatment:
Other: MRI
Idiopathic REM Sleep Behavior Disorder
Description:
Idiopathic REM Sleep Behavior Disorder
Treatment:
Other: MRI
Age-matched healthy controls
Description:
Age-matched healthy controls
Treatment:
Other: MRI

Trial contacts and locations

1

Loading...

Central trial contact

Matthew Brodsky, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems